34
Views
4
CrossRef citations to date
0
Altmetric
Review

Diastolic heart failure: recognition, diagnosis and management

, , &
Pages 1745-1754 | Published online: 25 Feb 2005

Bibliography

  • COWIE MR, WOOD DA, COATS AJ et al.: Incidence and aetiology of heart failure; a population-based study. Ear: Heart J. (1999) 20(6):421–428.
  • SENNI M TRIBOUILLOY CM RODEHEFFER RJ et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation (1998) 98(21):2282–2289.
  • VASAN RS LARSON MG BENJAMIN EJ et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol (1999) 33(7):1948–1955.
  • TSUTSUI H, TSUCHIHASHI M, TAKESHITA A: Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am. J. Cardiol (2001) 88(5):530–533.
  • TAFFET GE, TEASDALE TA, BLEYER AJ, KUTKA NJ, LUCHI RJ: Survival of elderly men with congestive heart failure. Age. Ageing (1992) 21(1):49–55.
  • KUPARI M, LINDROOS M, IIVANAINEN AM, HEIKKILA J, TILVIS R: Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J. Intern. Med. (1997) 241(5):387–394.
  • MCALISTER FA, TEO KK, TAHER M et al.: Insights into the contemporary epidemiology and out-patient management of congestive heart failure. Am. Heart J. (1999) 138(1 Pt 1):87–94.
  • MCDERMOTT MM, FEINGLASS J, LEE PI et al.: Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am. Heart J. (1997) 134(0728–736.
  • PERNENKIL R, VINSON JM, SHAH AS et al.: Course and prognosis in patients or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am. Cardiol (1997) 79(2):216–219.
  • GAASCH WH: Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. "AMA (1994) 271(16):1276–1280.
  • GOTTDIENERJS, MCCLELLAND RL, MARSHALL R et al.: Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann. Intern. Med. (2002) 137(8):631–639.
  • KINNEY EL, WRIGHT RJ: Survival in patients with heart failure and normal basal systolic wall motion. Angiology (1989) 40(12):1025–1029.
  • COHN JN, JOHNSON G: Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation (1990) 81(2 Suppl.):11148–11153.
  • ARONOW WS, AHN C, KRONZON I: Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am. J. Cardiol (1990) 66(17):1257–1259.
  • ANSARI M, ALEXANDER M, TUTAR A, MASSIE BM: Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am. Heart J. (2003) 146(1):115–120.
  • THOMAS JT, KELLY RF, THOMAS SJ et al.: Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am. I Med. (2002) 112(0437–445.
  • TARANTINI L, FAGGIANO P, SENNI M et al.: Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure out-patients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure. Ital. Heart J. (2002) 3(11):656–664.
  • PHILBIN EF, ROCCO TA Jr, LINDENMUTH NW, ULRICH K, JENKINS PL: Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am. J. Med. (2000) 109(8):605–613.
  • ZILE MR, BRUTSAERT DL: New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation (2002) 105(11):1387–1393.
  • ••A comprehensive review.
  • RAKOWSKI H, APPLETON C, CHAN KL et al.: Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. I Am. Soc. Echocardiogr: (1996) 9(5):736–760.
  • EUROPEAN STUDY GROUP ON DIASTOLIC HEART FAILURE: How to diagnose diastolic heart failure. Eur. Heart J. (1998) 19(7):990–1003.
  • GARCIA MJ, THOMAS JD, KLEIN AL: New Doppler echocardiographic applications for the study of diastolic function. J. Am. Coll. Cardiol (1998) 32(4):865–875.
  • NISHIMURA RA, TAJIK AJ: Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J. Am. Coll. Cardiol (1997) 30(1):8–18.
  • COHEN GI, PIETROLUNGO JF, THOMAS JD, KLEIN AL: A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J. Am. Coll. Cardiol (1996) 27(7):1753–1760.
  • VASAN RS, LEVY D: Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 101(17):2118–2121.
  • LITTLE WC, DOWNES TR, APPLEGATE RJ: Invasive evaluation of left ventricular diastolic performance. Herz (1990) 15(6):362–376.
  • OMMEN SR, NISHIMURA RA: A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart (2003) 89\(Suppl. 3):ili18-lii23.
  • CHOONG CY, HERRMANN HC, WEYMAN AE, FIFER MA: Preload dependence of Doppler-derived indices of left ventricular diastolic function in humans. J. Ant. Coll. Cardiol (1987) 10(4):800–808.
  • OH JK, APPLETON CP, HATLE LK, NISHIMURA RA, SEWARD JB, TAJIK AJ: The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography." Am. Soc. Echocardiogr. (1997) 10(3):246–270.
  • KEREN G, SHEREZ J, MEGIDISH R, LEVITT B, LANIADO S: Pulmonary venous flow pattern - its relationship to cardiac dynamics. A pulsed Doppler echocardiographic study. Circulation (1985) 71(6):1105–1112.
  • BRUNAZZI MC, CHIRILLO F, PASQUALINI M et al.: Estimation of left ventricular diastolic pressures from precordial pulsed-Doppler analysis of pulmonary venous and mitral flow. Am. Heart J. (1994) 128(2):293–300.
  • NISHIMURA RA, ABEL MD, HATLE LK, TAJIK AJ: Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography. Effect of different loading conditions. Circulation (1990) 81(5):1488–1497.
  • ROSSVOLL O, HATLE LK: Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures." Am. Coll. Cardiol (1993) 21(7):1687–1696.
  • BRUNAZZI MC, CHIRILLO F, PASQUALINI M et al.: Estimation of left ventricular diastolic pressures from precordial pulsed-Doppler analysis of pulmonary venous and mitral flow. Am. Heart J. (1994) 128(2):293–300.
  • STEEN T, ROOTWELT K, RISOE C, ANDREASSEN AK, IHLEN H: A new colour M-mode index of diastolic filling compared with radionuclide ventriculography. Int. J. Cardiol (1995) 48(1):89–95.
  • THOMAS JD, GARCIA MJ, GREENBERG NL: Application of colour Doppler M-mode echocardiography in the assessment of ventricular diastolic function: potential for quantitative analysis. Heart Vessels (1997) (Suppl. 12):135–137.
  • HURRELL DG, NISHIMURA RA, ILSTRUP DM, APPLETON CP: Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous catheterization and Doppler echocardiographic study." Am. Coll. Cardiol (1997) 30(2):459–467.
  • SOHN DW CHAI IH LEE DJ et al.: Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. I Am. Coll. Cardiol (1997) 30(2):474–480.
  • GARCIA MJ, RODRIGUEZ L, ARES M et al.: Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristic findings in normal subjects. Am. Heart j (1996) 132(3):648–656.
  • NAGUEH SF, MIDDLETON KJ, KOPELEN HA, ZOGHBI WA, QUINONES MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J. Am. Coll. Cardiol (1997) 30(6):1527–1533.
  • NAGUEH SF, MIKATI I, KOPELEN HA,MIDDLETON KJ, QUINONES MA, ZOGHBI WA: Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation (1998) 98(16):1644–1650.
  • OMMEN SR NISHIMURA RA APPLETON CP et al.: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation (2000) 102(15):1788–1794.
  • SKALUBA SJ, LITWIN SE: Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation (2004) 109(8):972–977.
  • BACHARACH SL, GREEN MV, BORER JS: Instrumentation and data processing in cardiovascular nuclear medicine: evaluation of ventricular function. Semin. Nucl. Med. (1979) 9(4):257–274.
  • KLOCKE FJ BAIRD MG LORELL BH et al.: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation (2003) 108(11):1404–1418.
  • CHEUNG BM, KUMANA CR: Natriuretic peptides-relevance in cardiovascular disease. "AMA (1998) 280(23):1983–1984.
  • COWIE MR, STRUTHERS AD, WOOD DA et al.: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 350(9088):1349–1353.
  • MCDONAGH TA, ROBB SD, MURDOCH DR et al: Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 351(9095):9–13.
  • YU CM, SANDERSON JE, SHUM 10 et al.: Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur. Heart I. (1996) 17(11):1694–1702.
  • LUBIEN E DEMARIA A KRISHNASWAMY P et al.: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation (2002) 105(5):595–601.
  • YAMAGUCHI H YOSHIDA J YAMAMOTO K et al.: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. I Am. Coll. Cardiol (2004) 43(1):55–60.
  • KAZANEGRA R, CHENG V, GARCIA A et al.: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. I Card. Fail. (2001) 7(1):21–29.
  • ZILE MR: Heart failure with preserved ejection fraction: is this diastolic heart failure?' Am. Coll. Cardiol (2003) 41(9):1519–1522.
  • ZILE MR, BRUTSAERT DL: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation (2002) 105(12):1503–1508.
  • ••A comprehensive review.
  • WEI JY: Age and the cardiovascular system. N Engl. J. Med. (1992) 327(24):1735–1739.
  • SHANNON RP, WEI JY, ROSA RM, EPSTEIN FH, ROWE JW: The effect of age and sodium depletion on cardiovascular response to orthostasis. Hypertension (1986) 8(5):438–443.
  • SNYDER NA, FEIGAL DW, ARIEFF Al: Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann. Intern. Med. (1987) 107(3):309–319.
  • COHN JN: The management of chronic heart failure. N Engl. I Med. (1996) 335(7):490–498.
  • VAN KRAAIJ DJ, JANSEN RW, GRIBNAU FW, HOEFNAGELS WH: Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction. Drugs Ageing (2000) 16(4):289–300.
  • VAN KRAAIJ DJ, JANSEN RW, BOUWELS LH, GRIBNAU FW, HOEFNAGELS WH: Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. Am. J. Cardiol. (2000) 85(12):1461–1466.
  • LEVY D, LARSON MG, VASAN RS, KANNEL WB, HO KK: The progression from hypertension to congestive heart failure. "AMA (1996) 275(20):1557–1562.
  • WEBER KT, SUN Y, GUARDA E: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension (1994) 23(6 Pt 2):869–877.
  • BONOW RO, UDELSON JE: Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann. Intern. Med. (1992) 117(6):502–510.
  • GROSSMAN W: Diastolic dysfunction in congestive heart failure. N Engl. J. Med. (1991) 325(22):1557–1564.
  • BRILLA CG, JANICKI JS, WEBER KT: Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ. Res. (1991) 69(1):107–115.
  • ROSENDORFF C: The renin-angiotensin system and vascular hypertrophy. I. Am. Cardiol. (1996) 28(4):803–812.
  • CARSON P, JOHNSON G, FLETCHER R, COHN J: Mild systolic dysfunction in heart failure (left ventricular ejection fraction 35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). I. Am. Coll Cardiol. (1996) 27(3):642–649.
  • YALCIN F, AKSOY FG, MUDERRISOGLU H, SABAH I, GARCIA MJ, THOMAS JD: Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function. Clin. Cardiol. (2000) 23(6):437–441.
  • ERIKSSON SV, KJEKSHUS J, OFFSTAD J, SWEDBERG K: Patient characteristics in cases of chronic severe heart failure with different degrees of left ventricular systolic dysfunction. Cardiology (1994) 85(3-4):137–144.
  • ZI M, CARMICHAEL N, LYE M: The effect of quinapril on functional status of elderly patients with diastolic heart failure. Cardiovasc. Drugs Ther. (2003) 17(2):133–139.
  • CHENG CP, SUZUKI M, OHTE N, OHNO M, WANG ZM, LITTLE WC: Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure. Circ. Res. (1996) 78(5):880–892.
  • YOSHIDA J YAMAMOTO K MANO T et al.: Angiotensin II Type 1 and endothelin type A receptor antagonists modulate the extracellular matrix regulatory system differently in diastolic heart failure. Hypertens. (2003) 21(2):437–444.
  • SAKATA Y, YAMAMOTO K, MANO T et al.: Angiotensin II Type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix. Hypertens. (2003) 21(9):1737–1745.
  • DIEZ J, QUEREJETA R, LOPEZ B, GONZALEZ A, LARMAN M, MARTINEZ UBAGO JL: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation (2002) 105(21):2512–2517.
  • WARNER JG JR, METZGER DC, KITZMAN DW, WESLEY DJ, LITTLE WC: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J. Am. Coll Cardiol. (1999) 33(6):1567–1572.
  • AYOUB JC, VITOLA JV, PARRO A Jr et al.: Losartan improves diastolic ventricular filling of hypertensive patients with diastolic dysfunction. Hypertens. Res. (1999) 22(2):155–159.
  • YUSUF S, PFEFFER MA, SWEDBERG K et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet (2003) 362(9386):777–781.
  • ••The only randomised, controlled trial.
  • ZANNAD F, DOUSSET B, ALLA F: Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension (2001) 38(5):1227–1232.
  • YU CM, WANG Q, LAU CP et al: Reversible impairment of left and right ventricular systolic and diastolic function during short-lasting atrial fibrillation in patients with an implantable atrial defibrillator: a tissue Doppler imaging study. Pacing Clin. Electrophysiol. (2001) 24(6):979–988.
  • LIU CP, TING CT, LAWRENCE W, MAUGHAN WL, CHANG MS, KASS DA: Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants. Circulation (1993) 88(4 Pt 1):1893–1906.
  • MULIERI LA, HASENFUSS G, LEAVITT B, ALLEN PD, ALPERT NR: Altered myocardial force-frequency relation in human heart failure. Circulation (1992) 85(5):1743–1750.
  • ARONOW WS, AHN C, KRONZON I: Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am. J. Cardiol. (1997) 80(2)207–209.
  • QUAIFE RA, GILBERT EM, CHRISTIAN PE et al.: Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am. Cardiol. (1996) 78(7):779–784.
  • PALAZZUOLI A, CARRERA A, CALABRIA P et al.: Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure. Am. Heart (2004) 147(1):E2.
  • BONOW RO, LEON MB, ROSING DR et al.: Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation (1982) 65(7):1337–1350.
  • BONOW RO, DILSIZIAN V, ROSING DR, MARON BJ, BACHARACH SL, GREEN MV: Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertropic cardiomyopathy. Circulation (1985) 72(4):853–864.
  • ARRIGHI JA, DILSIZIAN V, PERRONE-FILARDI P, DIODATI JG, BACHARACH SL, BONOW RO: Improvement of the age-related impairment in left ventricular diastolic filling with verapamil in the normal human heart. Circulation (1994) 90(1):213–219.
  • LAHIRI A, RODRIGUES EA, CARBONI GP, RAFTERY EB: Effects of long-term treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure. Circulation (1990) 81(2 Suppl.):III130–111138.
  • SETARO JF, ZARET BL, SCHULMAN DS, BLACK HR, SOUFER R: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am. J. Cardiol (1990) 66(12):981–986.
  • HUNG MJ, CHERNG WJ, KUO LT, WANG CH: Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure. Int. J. Clin. Piaci (2002) 56(1):57–62.
  • The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl. J. Med. (1997) 336(8):525–533.
  • ZILE MR: Diastolic heart failure. Diagnosis, prognosis, treatment. Minerva Cardioangiol (2003) 51(2):131–142.
  • BANERJEE P, BANERJEE T, KHAND A, CLARK AL, CLELAND JG: Diastolic heart failure: neglected or misdiagnosed? J. Am. Coll. Cardiol (2002) 39(1):138–141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.